Abbott’s (ABT) diversified business portfolio is well-positioned to drive continued momentum in 2025 amid foreign exchange headwinds. The stock carries a Zacks Rank #3 (Hold).Factors Driving ABT SharesWithin its Established Pharmaceuticals Division (EPD) business, Abbott, leveraging its leading presence in emerging markets, enjoys a unique opportunity to scale a licensing model that is capital-efficient and can bring access to life-changing medicines to the emerging market population. Abbott’s EPD sales in ...